## Abstract We utilized SEREX immunoscreening to identify a set of novel tumor antigens that are associated with human serous ovarian cancer and may prove useful for the early detection and treatment of this disease. Extensive screening with a panel of sera from 25 lateβstage ovarian cancer patient
Ovarian tumor antigens
β Scribed by Malaya Bhattacharya; Joseph J. Barlow
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 396 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The authors studied data of combination assays of tumor markers, because simultaneous elevation of different types of tumor markers in the serum was puzzling. They interpreted such phenomena regarding cancer antigen 125, carcinoernbryonic antigen, and carbohydrate determinant 19-9 in ovarian tumors.
The immunoreactivity of monoclonal antibody (MoAb) B72.3 with ovarian serous tumors of borderline malignancy from 44 women who were pregnant, were on hormone medication containing a progestin, or were known to be in the secretory phase of the menstrual cycle, was compared with that of similar tumors
## BACKGROUND. A large number of monoclonal antibodies (MoAhs) against human tumor cells have been generated and it has been shown that these MoAbs are useful tools in the diagnosis and treatment of cancer patients, as well as in the basic investigation of the oncogenesis and characterization of c
A case of extrarenal Wilms' tumor presenting as an ovarian mass in a woman 56 years of age is described. Histologically, glomeruloid and tubular structures were identified within nests of undifferentiated epithelium. No teratomatous components were encountered. A review of the literature found three